NFKB1 and atherosclerosis: Additionally, the TNF and NF‐κB signaling pathways highlight the contribution of systemic inflammation originating from the liver (“hepatic‐inflammatory axis”) to endothelial dysfunction, a hallmark of atherosclerosis and CHD [33].